Skip to main content

A highly accurate breast cancer diagnostic test for effective personalized treatment and assessment of therapy response.

Project description

Novel breast cancer diagnostic test for personalised treatment

Breast cancer (BC) is the most common cancer in women worldwide, but current diagnostic tests lack precision, often leading to misdiagnosis and inaccurate treatment. The goal of the EU-funded Multiplex8+ project is the development of a personalised and precise diagnostic test for early and late-stage BC. The test combines two patented multiplexed cancer diagnostic technologies: visualisation (RNA FISH) and RNA sequencing. The combination of these technologies will help to eliminate misdiagnosis and will enable a specific BC barcode system to suggest a particular personalised treatment and estimate its length and prognostic value. The current project stage involves establishing an accredited laboratory for clinical validation followed by the creation of the first high-value biotech company in Slovakia.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-EIC-SMEInst-2018-2020-3

Coordinator

MULTIPLEXDX S.R.O.
Net EU contribution
€ 2 449 527,50
Address
Ilkovicova 8
841 04 Bratislava
Slovakia

See on map

Region
Slovensko Bratislavský kraj Bratislavský kraj
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 1 049 797,50